Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cencora (COR)
NYSE:COR
Cencora (COR) Stock Price & Analysis
889 Followers
COR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$161.80 - $246.19
Previous Close$221
Volume1.42M
Average Volume (3M)1.23M
Market Cap
$44.08B
Enterprise Value$46.13B
Total Cash (Recent Filing)$2.87B
Total Debt (Recent Filing)$4.78B
Price to Earnings (P/E)24.2
Beta0.46
Next Earnings
Jul 31, 2024EPS Estimate
$3.2Last Dividend Ex-Date
May 09, 2024Dividend Yield0.9%
Share Statistics
EPS (TTM)9.14
Shares Outstanding199,451,791
10 Day Avg. Volume1,255,806
30 Day Avg. Volume1,226,424
Standard Deviation0.06
R-Squared0.19
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-3.38
Price to Sales (P/S)0.64
Price to Cash Flow (P/CF)12.50
P/FCF Ratio13.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.17
Enterprise Value/Gross Profit5.15
Enterprise Value/Ebitda17.06
Forecast
1Y Price Target
$262.33Price Target Upside20.84% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Cencora News
PremiumCompany Announcements
Cencora EVP Gina K. Clark Announces Amicable Retirement
PremiumCompany Announcements
Cencora Schedules Fiscal Quarter Results Discussion Webcast
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company's core performance remains strong, with solid EBIT growth even with overall headwinds from Covid antivirals.
Leadership And StrategyCEO Steve Collis is leaving Cencora well positioned for sustained long-term growth and cash flow generation.
Market PositionCOR is a leading U.S. pharmaceutical distributor, the largest specialty distributor, and a leader in pharmacy support services.
Bears Say
Financial PerformanceUS revenue missed Street and growth slowed notably, with various ecosystem items causing concern among investors.
LeadershipConcerns over CEO transition and increased competitive dynamics among distributors.
Operational HealthNet Cash from Operations of -$878MM was down significantly and below estimates.
---
Ownership Overview
15.58% Insiders
26.88% Mutual Funds
51.33% Other Institutional Investors
6.22% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
COR FAQ
What was Cencora’s price range in the past 12 months?
Cencora lowest stock price was $161.80 and its highest was $246.19 in the past 12 months.
What is Cencora’s market cap?
Currently, no data Available
When is Cencora’s upcoming earnings report date?
Cencora’s upcoming earnings report date is Jul 31, 2024 which is in 71 days.
How were Cencora’s earnings last quarter?
Cencora released its earnings results on May 01, 2024. The company reported $3.8 earnings per share for the quarter, beating the consensus estimate of $3.694 by $0.106.
Is Cencora overvalued?
According to Wall Street analysts Cencora’s price is currently Undervalued.
Does Cencora pay dividends?
Cencora pays a Quarterly dividend of $0.51 which represents an annual dividend yield of 0.9%. See more information on Cencora dividends here
What is Cencora’s EPS estimate?
Cencora’s EPS estimate is $3.2.
How many shares outstanding does Cencora have?
Cencora has 199,451,800 shares outstanding.
What happened to Cencora’s price movement after its last earnings report?
Cencora reported an EPS of $3.8 in its last earnings report, beating expectations of $3.694. Following the earnings report the stock price went down -4.121%.
Which hedge fund is a major shareholder of Cencora?
Among the largest hedge funds holding Cencora’s share is Antipodes Partners Ltd. It holds Cencora’s shares valued at 120M.
---
Cencora Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$262.33 (20.84% Upside)
$262.33 (20.84% Upside)
Blogger Sentiment
Bullish
COR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 212.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.0%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.69%
12-Months-Change
Fundamentals
Return on Equity
271.45%
Trailing 12-Months
Asset Growth
8.68%
Trailing 12-Months
Company Description
Cencora
Cencora, Inc. engages provision of pharmaceutical products and business solutions that improve access
to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical
Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic
pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded
sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and
health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate
site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and
includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.
---
COR Company Deck
---
COR Earnings Call
Q2 2024
0:00 / 0:00
---
COR Revenue Breakdown
87.62% Human Health
8.52% Alliance Healthcare
1.93% Other Healthcare Solutions
1.92% Animal Health
---
COR Stock 12 Month Forecast
Average Price Target
$262.33
▲(20.84% Upside)
Technical Analysis
Best Analysts Covering COR
1 Year
1 Year Success Rate
15/17 ratings generated profit
1 Year Average Return
+18.70%
reiterated a buy rating 4 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +18.70% per trade.
---